Furthermore, this notion of the existence of 25(OH)D metabolism by PTH and FGF23 in CKD patient kidneys is supported by recent reports showing that FGF23 neutralization by anti-FGF23 antibody treatment significantly increased serum 1,25(OH)2D in CKD mice34 and rats35,36. This evidence concerns the gene PTH and chronic kidney disease.